DrugPatentWatch Database Preview
Capsaicin - Generic Drug Details
What are the generic drug sources for capsaicin and what is the scope of patent protection?
Capsaicin
is the generic ingredient in one branded drug marketed by Averitas and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Capsaicin has sixteen patent family members in ten countries.
There are six drug master file entries for capsaicin. Two suppliers are listed for this compound.
Summary for capsaicin
International Patents: | 16 |
US Patents: | 1 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 6 |
Suppliers / Packagers: | 2 |
Bulk Api Vendors: | 100 |
Clinical Trials: | 163 |
Patent Applications: | 9,500 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for capsaicin |
DailyMed Link: | capsaicin at DailyMed |
Recent Clinical Trials for capsaicin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sahlgrenska University Hospital, Sweden | Phase 2 |
Vinnova | Phase 2 |
Toronto Rehabilitation Institute | Early Phase 1 |
Medical Subject Heading (MeSH) Categories for capsaicin
Synonyms for capsaicin
(6E)-N-(4-Hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide # |
(6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide |
(6E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide |
(6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide |
(E)-8-Methyl-N-vanillyl-6-nonenamide |
(E)-8-Methyl-N-vanillyl-6-nonenamide(8cl) |
(E)-Capsaicin |
(E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide |
(E)-N-(4-Hydroxy-3-methoxybenzyl) |
(e)-n-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide |
(E)-N-[(4-hydroxy-3-methoxy-phenyl)methyl]-8-methyl-non-6-enamide |
(E)-N-[(4-Hydroxy-3-methoxyphenyl)-methyl]-8-methyl-6-nonenamide |
(E)-N-[(4-HYDROXY-3-METHOXYPHENYL)METHYL]-8-METHYL-6-NONENAMIDE |
(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide |
(E)8-methyl-N-vanillyl-6-Nonenamide |
[(E)-N-(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide |
1217899-52-9 |
404-86-4 |
4CH-016296 |
6-Nonenamide, (E)- |
6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl |
6-Nonenamide, 8-methyl-N-vanillyl-, (E)- |
6-Nonenamide, 8-methyl-N-vanillyl-, (E)- (8CI) |
6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (6E)- |
6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (E)- |
6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (6E)- |
6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (E)- |
8-Methyl-N-Vanillyl-6-Nonenamide |
8-Methyl-N-vanillyl-6-nonenamide, (E)- |
8-Methyl-N-vanillyl-6E-nonenamide |
8-Methyl-N-vanillyl-trans-6-nonenamide |
912457-62-6 |
AB00053098_12 |
AB00053098-11 |
AC-10114 |
AC1LU7K3 |
AC1Q46B3 |
Adlea |
AJ-26667 |
AKOS007930159 |
ALGRX 4975 |
AN-23437 |
Ausanil |
Axsain |
BBL027836 |
BDBM20461 |
BDBM86537 |
Bitter orange extract 30% |
BPBio1_001053 |
BRD-K37056290-001-01-1 |
BRD-K50590187-001-06-6 |
BRN 2816484 |
BSPBio_000957 |
BSPBio_001548 |
BSPBio_002917 |
C06866 |
C18H27NO3 |
CAPSAICIN (2444-46-4 NONIVAMIDE (SYNTHETIC CAPSAICIN)) |
Capsaicin (in oleoresin of capsicum) |
Capsaicin (JAN/USP) |
Capsaicin (Natural) |
Capsaicin [in oleoresin of capsicum] |
Capsaicin [USAN] |
Capsaicin [USP:INN] |
Capsaicin Patch |
Capsaicin, >=95%, from Capsicum sp. |
Capsaicin, analytical standard |
Capsaicin, certified reference material, TraceCERT(R) |
Capsaicin, European Pharmacopoeia (EP) Reference Standard |
Capsaicin, from Capsicum sp., >=50% (HPLC) |
Capsaicin, from natural source |
CAPSAICIN, NATURAL |
Capsaicin, Pharmaceutical Secondary Standard; Certified Reference Material |
Capsaicin, United States Pharmacopeia (USP) Reference Standard |
Capsaicin,(S) |
Capsaicin(Qutenza) |
CAPSAICINE |
CAPSAICINOIDS |
Capsicin |
Capsicine |
CAS_404-86-4 |
CAS-404-86-4 |
Caswell No. 158 |
CC0144 |
CCG-39908 |
CCRIS 1588 |
CHEBI:3374 |
CHEBI:94524 |
CHEMBL294199 |
Citrus Aurantium 30% |
Citrus Aurantium Extract |
CITRUS AURANTIUM PE |
CJ-23980 |
CS-1518 |
D00250 |
DB06774 |
depletes Substance P |
DSSTox_CID_241 |
DSSTox_GSID_20241 |
DSSTox_RID_75455 |
DTXSID9020241 |
E-CAPSAICIN |
EI-125 |
EINECS 206-969-8 |
EPA Pesticide Chemical Code 070701 |
epsilon-capsaicin |
FEMA No. 3404 |
FT-0082538 |
GTPL2486 |
HMS1361N10 |
HMS1570P19 |
HMS1791N10 |
HMS1921H11 |
HMS1989N10 |
HMS2089N11 |
HMS2092D21 |
HMS2097P19 |
HMS2230O23 |
HMS3402N10 |
HMS3649N15 |
HMS501B16 |
HSDB 954 |
HY-10448 |
I01-2469 |
IDI1_000354 |
IDI1_034018 |
Isodecenoate |
Isodecenoic acid vanillylamide |
KS-5181 |
LMFA08020085 |
LS-2138 |
M1149 |
MCULE-8056866140 |
MEGxp0_001448 |
MFCD00017259 |
Mioton |
MLS002154049 |
MolPort-001-742-263 |
MR3H3 |
N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide |
N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide, (E)- |
N-(3-Methoxy-4-hydroxybenzyl)-8-methyl-6-nonenamide |
n-(4-hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide |
N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide |
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide |
N-[(4-hydroxy-3-methoxyphenyl)methyl]-6E-8-methyl-nonenamide |
N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide |
N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide |
N0C781 |
N1667 |
N735 |
NCGC00017337-02 |
NCGC00017337-03 |
NCGC00017337-04 |
NCGC00017337-05 |
NCGC00017337-06 |
NCGC00017337-07 |
NCGC00017337-08 |
NCGC00017337-09 |
NCGC00017337-10 |
NCGC00017337-11 |
NCGC00017337-12 |
NCGC00017337-13 |
NCGC00017337-18 |
NCGC00090853-01 |
NCGC00090853-02 |
NCGC00090853-03 |
NCGC00090853-04 |
NCGC00090853-06 |
NCGC00090853-07 |
NCGC00090853-08 |
NCGC00090853-09 |
NCGC00090853-10 |
NCGC00090853-11 |
NCGC00090853-12 |
NCGC00257869-01 |
NCI-C56564 |
neurotoxic |
NGX 4010 |
NGX-1998 |
NGX-3781 |
NGX-4010 |
NGX-7325 |
Nonenamide, 8-methyl-N-vanillyl-, (E)- |
Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8 -methyl-, (E)- |
NSC 56353 |
NSC_2548 |
NSC-56353 |
NSC-757844 |
NSC56353 |
NSC757844 |
Pharmakon1600-01501128 |
Prestwick_204 |
Prestwick2_000879 |
Prestwick3_000879 |
Qutenza |
RTC-030399 |
S07O44R1ZM |
SBI-0052593.P002 |
SC-19636 |
SCHEMBL8085 |
SCHEMBL8086 |
SDCCGMLS-0066678.P001 |
SMP2_000337 |
SMR000718774 |
SPECTRUM1501128 |
Spectrum5_000538 |
SR-05000001861 |
SR-05000001861-1 |
SR-05000001861-4 |
SR-05000001861-5 |
SR-05000001861-6 |
SR-05000001861-9 |
ST057183 |
STL372889 |
Styptysat |
TC-030399 |
TL8002946 |
TNP00277 |
Tox21_110817 |
Tox21_200315 |
TQ-1018 |
trans-8-Methyl-N-vanillyl-6-nonenamide |
trans-8-Methyl-N-vanillylnon |
trans-Capsaicin |
trans-Capsaicin-d3 |
trans-N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide |
Transacin |
UNII-S07O44R1ZM |
UNII-UW86K581WY component YKPUWZUDDOIDPM-SOFGYWHQSA-N |
UPCMLD-DP092 |
UPCMLD-DP092:001 |
UPCMLD-DP092:002 |
Vanilloid |
W-5044 |
YKPUWZUDDOIDPM-SOFGYWHQSA-N |
ZINC1530575 |
Zostrix |
ZOSTRIX (TN) |
Zostrix HP |
US Patents and Regulatory Information for capsaicin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for capsaicin
Country | Patent Number | Estimated Expiration |
---|---|---|
Germany | 69814917 | Start Trial |
Austria | 344023 | Start Trial |
European Patent Office | 1316308 | Start Trial |
Canada | 2314326 | Start Trial |
World Intellectual Property Organization (WIPO) | 9930560 | Start Trial |
Spain | 2196640 | Start Trial |
Germany | 69836352 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |